Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-01

Clinical Trial Update: A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates nicotinic acid for hand-foot skin reactions associated with VEGFR inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinic acid (niacin)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Hand-Foot Skin Reaction (HFSR) | Phase 2 | Status: UNKNOWN